Gilead's Kite Reports Initial Results From Phase 1 Study Of T-Cell Receptor Cell Therapy In HPV-16-Positive Solid Tumors: NCI Study Shows Investigational Therapy Induces Response In Patients with Epithelial Cancers
Benzinga Newsdesk